ECSP055997A - Vacuna de vibrio cholerae inactivada en tabletas - Google Patents

Vacuna de vibrio cholerae inactivada en tabletas

Info

Publication number
ECSP055997A
ECSP055997A EC2005005997A ECSP055997A ECSP055997A EC SP055997 A ECSP055997 A EC SP055997A EC 2005005997 A EC2005005997 A EC 2005005997A EC SP055997 A ECSP055997 A EC SP055997A EC SP055997 A ECSP055997 A EC SP055997A
Authority
EC
Ecuador
Prior art keywords
vibrio cholerae
vaccine
inactivated
tablets
vaccines
Prior art date
Application number
EC2005005997A
Other languages
English (en)
Inventor
Coronel Arturo Talavera
Lopez Gemma Ano
Fernandez Jorge Luis Castano
Hernandez Evangelina Urribarri
Perez Tania Balmaseda
Marrero Barbara Cedre
Imia Luis Garcia
Quinoy Jose Luis Perez
Suarez Caridad Torres
Navarro Yadira Pino
Sanchez Hilda Maria Garcia
Original Assignee
Inst Finlay Ct De Investigacio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finlay Ct De Investigacio filed Critical Inst Finlay Ct De Investigacio
Publication of ECSP055997A publication Critical patent/ECSP055997A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/107Vibrio
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/106Vibrio; Campylobacter; Not used, see subgroups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con el campo de las vacunas, específicamente con las vacunas de aplicación oral contra el cólera. El objetivo técnico que persigue es obtener una formulación en tabletas de vacunas de células enteras inactivadas de Vibrio cholerae. La invención describe la formulación del producto vacunal.
EC2005005997A 2003-03-20 2005-09-02 Vacuna de vibrio cholerae inactivada en tabletas ECSP055997A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20030061A CU23334A1 (es) 2003-03-20 2003-03-20 Vacuna de vibrio cholerae inactivada en tabletas

Publications (1)

Publication Number Publication Date
ECSP055997A true ECSP055997A (es) 2006-01-27

Family

ID=40203015

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005997A ECSP055997A (es) 2003-03-20 2005-09-02 Vacuna de vibrio cholerae inactivada en tabletas

Country Status (13)

Country Link
US (1) US20060246094A1 (es)
EP (1) EP1614427A1 (es)
JP (1) JP2006520332A (es)
KR (1) KR20050109978A (es)
CN (1) CN1791426A (es)
AR (1) AR043621A1 (es)
BR (1) BRPI0408409A (es)
CA (1) CA2519225A1 (es)
CU (1) CU23334A1 (es)
EC (1) ECSP055997A (es)
PE (1) PE20041064A1 (es)
WO (1) WO2004082711A1 (es)
ZA (1) ZA200507576B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9511133B2 (en) * 2009-09-16 2016-12-06 Msd Wellcome Trust Hilleman Laboratories Pvt Ltd. Vaccine against cholera and enterotoxigenic E. coli (ETEC) diarrhea
MY190074A (en) * 2018-01-09 2022-03-24 Aimst Univ A monovalent vaccine formulation and a method for preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62502262A (ja) * 1985-03-27 1987-09-03 ブロンコスタット・プロプライアタリー・リミテツド アジユバントを含有しないワクチン
US4871546A (en) * 1987-06-29 1989-10-03 Sandoz Pharm. Corp. Gastrointestinal protective coating formulations
IT1260505B (it) * 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
US6203799B1 (en) * 1993-07-01 2001-03-20 Presidents And Fellows Of Harvard College Vibrio cholerae mutants which are soft-agar penetration defective and lack a functional CtxA subunit

Also Published As

Publication number Publication date
BRPI0408409A (pt) 2006-03-21
US20060246094A1 (en) 2006-11-02
ZA200507576B (en) 2007-01-31
EP1614427A1 (en) 2006-01-11
KR20050109978A (ko) 2005-11-22
JP2006520332A (ja) 2006-09-07
CU23334A1 (es) 2008-12-24
AR043621A1 (es) 2005-08-03
WO2004082711A1 (es) 2004-09-30
CA2519225A1 (en) 2004-09-30
CN1791426A (zh) 2006-06-21
PE20041064A1 (es) 2005-03-02

Similar Documents

Publication Publication Date Title
CL2019000209A1 (es) Formulación novedosa administrable por la vía oral.
UY29395A1 (es) Formulación de medicamentos conteniendo vardenafilo.
UY30472A1 (es) Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones.
GT200600260A (es) Derivados de benzamida y usos relacionados con los mismos
GT200600445A (es) Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo.
CO6501190A2 (es) Vacuna de pcsk9
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
UY32240A (es) Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones.
UY29065A1 (es) Derivados del ácido alcanoico arilcicloalquil-sustituidos, procedimientos para su preparación y su uso como productos farmacéuticos.
TW200700062A (en) Pharmaceutical compositions
AR084865A1 (es) Preparacion de desintegracion rapida, comprimido dispersable por via oral
NO20084478L (no) Konjugerte lipidderivater
UY32190A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibdores de quinasas dependientes de ciclina (cdk), produccion y uso de los mismos como productos medicinales
UA99645C2 (ru) Гель, имеющий противовоспалительное и противоаллергическое действие
CO6420389A2 (es) Composiciones y métodos para el tratamiento y prevención de la enfermedad cardiovascular
ATE452120T1 (de) Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
CL2010000281A1 (es) Formulacion oral en forma de tableta de 9-[(2,2-dimetil-propilamino)-metil]-minociclina; metodo de preparacion; formulacion inyectable del mismo; utiles en el tratamiento de una infeccion.
ATE526015T1 (de) Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien
UY28210A1 (es) Derivados de ácido acético sustituido con cicloalquilmetoxi, procedimientos para su preparacion y su uso como farmacos.
ECSP055997A (es) Vacuna de vibrio cholerae inactivada en tabletas
BRPI0408848B8 (pt) composições farmacêuticas de complexo de ciclodextrina-cladribina complexo, usos do referido complexo, bem como processos para a sua preparação
MX2009012713A (es) Nuevos derivados de acido 3-fenil acrilico de receptores de tipo ppar, su metodo de preparacion y su uso en composiciones cosmeticas o farmaceuticas.
GT200800235A (es) Formulacion de medicamento liquida